Emmessar Biotech & Nutrition Ltd.

29.85 +0.59 ▲2.0%

28 March 2024, 04:01:00 PM
Volume: 9,023

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ebnl.org
Market Cap 14.85 Cr.
Enterprise Value(EV) 9.01 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 1.15 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 25.78 Trailing Twelve Months Ending 2023-12
Industry PE 41.54 Trailing Twelve Months Ending 2023-12
Book Value / Share 14.10 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.11 Calculated using Price: 29.72
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.50 Cr. 4,996,100 Shares
FaceValue 10
About Emmessar Biotech & Nutrition Ltd.
Emmessar Biotech & Nutrition Ltd., was originally started as Emmessar Chemical Industries Ltd on March 17,1992, for manufacturing Super Speciality Fine Chemicals. The Company succeeded in developing many Speciality Fine Chemicals in its own In-house R&D, which was recognised on January 15, 1996 by DSIR, Ministry of Science & Technology, Government of India, New Delhi .

Emmessar Biotech & Nutrition Ltd. Delivery

Delivered Qty
Traded Qty

Emmessar Biotech & Nutrition Ltd. Performance

1 Day
+2.02%
1 Week
+2.51%
1 Month
-26.50%
3 Month
+13.93%
6 Month
+20.80%
1 Year
+18.45%
2 Year
+11.80%
5 Year
+71.55%
10 Year
+575.34%

Emmessar Biotech & Nutrition Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -7.98 -40.75 78.73 36 16.42 19.4 29.1 8.01 7.85
Return on Capital Employed (%) -10.49 -59.37 79.46 31.46 9 18.87 45.29 15.71 14.99
Return on Assets (%) -5.08 -20.32 44.83 26.93 12.75 14.93 22.47 6.3 6.42

Emmessar Biotech & Nutrition Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 1 1 2 3 4 4 6 6 7 7
Non Curr. Liab. 0 1 1 0 0 0 0 1 1
Curr. Liab. 1 1 0 0 1 1 2 1 1 0
Minority Int.
Equity & Liab. 2 2 3 4 5 5 7 8 8 8
Non Curr. Assets 2 1 2 2 2 2 2 2 2 2
Curr. Assets 1 1 1 1 3 3 6 6 6 6
Misc. Exp. not W/O
Total Assets 2 2 3 4 5 5 7 8 8 8

Emmessar Biotech & Nutrition Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 2 2 3 1 1 3 7 0 1 1
Other Income 0 0 1 1 1 1 1 2 2 2
Total Income 2 2 4 3 2 5 8 2 3 3
Total Expenditure -2 -2 -2 -2 -1 -4 -6 -1 -2 -2
PBIDT 0 0 1 1 1 1 2 1 1 1
Interest 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 -1 0 0 0
Exceptional Items -1 0 0
PAT 0 0 1 1 1 1 1 0 1 1
Adjusted EPS 0 -1 2 2 1 2 3 1 1 1

Emmessar Biotech & Nutrition Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 1 1 0 1 0 2 0
Cash Fr. Inv. 0 -1 -1 0 -1 0 -3 -1
Cash Fr. Finan.
Net Change 0 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 1 0 0

Emmessar Biotech & Nutrition Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 58.50 58.51 58.19 56.31 58.53 59.08 58.19 59.53 59.53
Public 41.50 41.49 41.81 43.69 41.47 40.92 41.81 40.47 40.47
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Emmessar Biotech & Nutrition Ltd. Announcements

Wed, 27 Mar 2024
Closure of Trading Window
Pursuant to Clause 4 of Schedule B of PIT Regulations 2015 as amended the Trading Window of the company for dealing in securities will remain closed w.e.f. April 01 2024 till May 31 2024 for considering the Financial Results for the quarter/year ending March 31 2024. All insiders/designated persons their relatives are advised not to trade in the securities of the company during the above period.
Wed, 20 Mar 2024
Board Meeting Outcome for Appointment Of Independent Director
Pursuant to Reg 30 LODR Reg 2015 Mr. Dinesh Kumar Deora is appointed as Additional Independent Director w.e.f. 20.03.2024
Tue, 27 Feb 2024
Board Meeting Intimation for Appointment Of Independent Director
EMMESSAR BIOTECH & NUTRITION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/03/2024 inter alia to consider and approve inducting / appointing an Independent Director on the Board of Directors

Emmessar Biotech & Nutrition Ltd. Technical Scans

Thu, 28 Mar 2024
High Delivery Percentage High Delivery Percentage
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 3 Months High Increase in 3 Months
CCI Bullish CCI Bullish
MFI Below 20 MFI Below 20

Emmessar Biotech & Nutrition Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 388,812.23 1,620.50 +0.8%
Cipla Ltd. 120,673.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. 102,679.14 6,171.85 +2.0%
Zydus Lifesciences Ltd. 101,151.67 1,007.35 +0.8%
Mankind Pharma Ltd. 92,029.19 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. 91,330.58 6,347.35 +1.9%
Divi's Laboratories Ltd. 91,234.91 3,452.55 +2.6%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 43.66 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 32.54 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.64 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 34.01 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 53.29 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.71 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 65.97 3,452.55 +2.6%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.23 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-12 4.66 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.82 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.37 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-12 10.36 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.52 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-12 7.00 3,452.55 +2.6%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 0.02 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 12.85 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,452.55 +2.6%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,452.55 +2.6%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,620.50 +0.8%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,494.65 +1.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,171.85 +2.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 1,007.35 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,300.75 -1.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,347.35 +1.9%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,452.55 +2.6%

Emmessar Biotech & Nutrition Ltd. FAQ's

What is Emmessar Biotech&Nut share price?

Can I buy Emmessar Biotech&Nut shares now?

What is the Market Cap of Emmessar Biotech&Nut?

What are the key metrics to analyse Emmessar Biotech&Nut?

What is the 52 Week High and Low of Emmessar Biotech&Nut?

What is the trend of Emmessar Biotech&Nut share price?